<!DOCTYPE html><html><head>   <meta>     <title>Pfizer warns Biden price controls could hurt cancer drugs development</title>   </meta>   <style>
.youtube_player_container {
    position: relative;
    width: 50%;
    padding-bottom: 26.25%;
    /* background-color: yellow; */
}
.youtube_player_frame {
    position: absolute;
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    border: 0;
}
       </style></head><body><a href="index.html"><h2>Index</h2></a><a href="https://www.ft.com/content/b3ae2a1b-0c83-4535-bb0e-d10fadac1de1"><div><img style="width:400px;height=300px" src="https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fcc62afc5-8d1a-46f5-89bf-9023505ab06d.jpg?source=next-home-page&dpr=2&width=580&fit=scale-down" /></div><h1>[1144000] Pfizer warns Biden price controls could hurt cancer drugs development</h1></a><div>https://www.ft.com/rss/home</div><div>2024-09-14 08:15:19+00:00</div><div><pre>Companyâ€™s chief oncology officer says reforms risk discouraging treatments for paediatric and rare conditions</pre></div></body></html>